Drugs and Society Discussion Post Responses

Prevention programs are not evaluated long enough to see real long-term results. Over several years people have misused drugs for their own purpose. Leading their actions to consequences in the long run. It can affect their overall health and safety. These programs were designed to stop or delay drug use. While many programs evaluate short term outcomes, long term is the most effective. They are funded through private organizations or grants to continue their line of work. At the beginning their demand was to produce measurable outcomes, improve attitudes, and discover new information through the cycle. Long term studies may attend to tracking their patients. Although it can be difficult considering they might relocate or stop their tracking, it can become expensive to keep the programs running and try to produce realistic studies. Creating complications by producing long term results. Research shows prevention programs can reduce risky behavior that focuses on community support and involvement with families. From my perspective I believe long term prevention programs will show better results than short term. By having stable funding and longer evaluations can reduce substance use.

Scout Bell:

Harm reduction programs like needle exchanges, medical amnesty, and overdose prevention centers, have consistently been shown to reduce HIV and hepatitis c transmission. However, they are often criticized in the United States as enabling drug use. Viewing harm reduction this way seems to reflect deeper cultural beliefs about the value of punishment over public health in the US. Harm reduction programs also significantly lowers healthcare costs by preventing the spread of diseases and reducing overdoses and deaths. If money and lives are being saved, and other countries have proved it can be successful, why is the harm reduction approach such a political issue in the US?

Safe housing, access to food, strong social support, and healthcare access play an important role in reducing harm and promoting recovery. This is vastly more effective than harsh judgments and criminalization. Stigma and fear of punishment commonly leads to more unsafe and risky behavior which makes the drug problem worse. Harm reduction programs don’t increase substance use or promote criminality, they often increase the likelihood of someone going to treatment for substance use. I think the hesitancy to implement these strategies on a large scale reflects the American emphasis on punishment and stigma, shaped by the history of the United States through movements like the war on drugs.

Helen Grizzle:

Harm reduction is a public health approach designed to minimize the negative health, social, and legal consequences of drug use without requiring abstinence as a precondition for support. It focuses on "meeting people where they are" by offering compassionate, non-judgmental services to people who use drugs. Key components in the U.S. include: Naloxone distribution: Kits to reverse opioid overdoses. Syringe Service Programs (SSPs): Providing sterile needles to prevent HIV and hepatitis C. Drug -checking: Utilizing fentanyl test strips to identify contamination in the drug supply. Medication-Assisted Treatment (MAT): Offering methadone or buprenorphine to reduce cravings. It does not enable drug use; no evidence shows harm reduction by doing so, but rather acts as a bridge to, not a roadblock to, recovery. Studies show that people who use harm reduction services are five times more likely to enter drug treatment and three times more likely to reduce or stop injecting than those who do not use these services.

Lucy Harvey:

When implementing drug harm reduction U.S. it would require coordinated changes in law, public health policy, funding, and culture. In many European countries such as the Netherlands, their culture chooses to treat drug use primarily as a public health issue rather than a criminal one. The U.S. could adapt several of the models that Europe implements such as providing sterile equipment, connecting people to treatment and housing, and supervising injections to prevent accidental overdose. The United States would have to try startup programs in high-rated overdose cities such as New York City and San Francisco. Funding would be a big issue for it all, so the CDC and state health departments would have to figure that out.

All of these examples of drug harm reduction have been proven to work especially in the Netherlands, and the EU as a whole with, "50 years of harm reduction in Europe."